
CDCR
More and more states are shifting to a new execution drug, pentobarbital, in the wake of an international controversy that essentially resulted in the end of sodium thiopental production by the American company, Hospira. Hospira had always been uncomfortable with its product’s use in the lethal injection process–sodium thiopental, an anesthetic, is also used by hospitals and clinics. After a raw material shortage slowed sodium thiopental production by Hospira in the United States, many states, including California, looked for the drug abroad, and ended up importing it from distributors in the United Kingdom. (Georgia’s supply has since been seized by the Drug Enforcement Administration, which is investigating the transaction.) Hospira later announced that they’re leaving the sodium thiopental business altogether, in response to outrage in Europe over European-made drugs ending up in US executions. The announcement meant states started looking for alternatives–and now, a new execution drug has emerged.
Continue reading →